TRCT
BBH icon

Tower Research Capital (TRC)’s VanEck Biotech ETF BBH Stock Holding History

Tower Research Capital (TRC)’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-260
Closed -$43.1K – 5147
2025
Q3 		$43.1K Sell
260
-2,737
-91% -$446K ﹤0.01% 2641
2025
Q2 		$459K Sell
2,997
-1,191
-28% -$177K 0.01% 1056
2025
Q1 		$659K Buy
4,188
+1,590
+61% +$258K 0.02% 695
2024
Q4 		$408K Buy
2,598
+702
+37% +$118K 0.01% 1212
2024
Q3 		$336K Buy
1,896
+441
+30% +$78.2K 0.01% 1161
2024
Q2 		$245K Buy
1,455
+150
+11% +$24.5K ﹤0.01% 1917
2024
Q1 		$217K Buy
1,305
+1,058
+428% +$175K 0.01% 1360
2023
Q4 		$40.8K Sell
247
-1,625
-87% -$250K ﹤0.01% 3261
2023
Q3 		$292K Sell
1,872
-1,743
-48% -$278K 0.01% 1204
2023
Q2 		$564K Sell
3,615
-436
-11% -$69.7K 0.02% 893
2023
Q1 		$657K Buy
4,051
+1,125
+38% +$182K 0.02% 674
2022
Q4 		$467K Buy
2,926
+243
+9% +$38.5K 0.02% 743
2022
Q3 		$377K Sell
2,683
-2,422
-47% -$366K 0.01% 1363
2022
Q2 		$744K Buy
5,105
+4,651
+1,024% +$693K 0.02% 880
2022
Q1 		$74K Sell
454
-1,633
-78% -$264K ﹤0.01% 2416
2021
Q4 		$396K Sell
2,087
-1,050
-33% -$202K 0.01% 1273
2021
Q3 		$634K Buy
3,137
+558
+22% +$117K 0.02% 826
2021
Q2 		$520K Buy
2,579
+1,185
+85% +$221K 0.01% 1158
2021
Q1 		$245K Sell
1,394
-304
-18% -$55K ﹤0.01% 1839
2020
Q4 		$288K Sell
1,698
-275
-14% -$45.3K 0.01% 1424
2020
Q3 		$320K Buy
1,973
+1,713
+659% +$279K ﹤0.01% 2121
2020
Q2 		$42K Buy
+260
New +$39.5K ﹤0.01% 3174
2020
Q1 		– Sell
-322
Closed -$45K – 3046
2019
Q4 		$45K Sell
322
-3,654
-92% -$480K ﹤0.01% 1404
2019
Q3 		$470K Buy
3,976
+2,734
+220% +$340K 0.03% 588
2019
Q2 		$160K Sell
1,242
-782
-39% -$96.4K 0.01% 952
2019
Q1 		$261K Sell
2,024
-10,073
-83% -$1.27M 0.02% 1014
2018
Q4 		$1.34M Buy
12,097
+7,629
+171% +$922K 0.1% 206
2018
Q3 		$607K Sell
4,468
-3,248
-42% -$422K 0.04% 391
2018
Q2 		$926K Sell
7,716
-1,040
-12% -$123K 0.05% 376
2018
Q1 		$1.05M Sell
8,756
-1,207
-12% -$151K 0.09% 182
2017
Q4 		$1.24M Buy
9,963
+9,709
+3,822% +$1.24M 0.16% 142
2017
Q3 		$34K Sell
254
-323
-56% -$42.1K ﹤0.01% 2317
2017
Q2 		$72K Sell
577
-28,765
-98% -$3.47M 0.01% 609
2017
Q1 		$3.49M Buy
29,342
+25,887
+749% +$3.03M 0.35% 32
2016
Q4 		$372K Sell
3,455
-236
-6% -$25.7K 0.04% 432
2016
Q3 		$425K Buy
3,691
+1,660
+82% +$189K 0.04% 204
2016
Q2 		$208K Sell
2,031
-160
-7% -$17.1K 0.02% 639
2016
Q1 		$227K Sell
2,191
-4,678
-68% -$488K 0.03% 297
2015
Q4 		$872K Sell
6,869
-28,466
-81% -$3.49M 0.14% 94
2015
Q3 		$4.04M Buy
+35,335
New +$4.68M 0.39% 31
2015
Q2 		– Sell
-37,366
Closed -$4.84M – 4375
2015
Q1 		$4.84M Buy
37,366
+37,198
+22,142% +$4.67M 0.6% 16
2014
Q4 		$19K Buy
+168
New +$18.9K ﹤0.01% 1625
2014
Q3 		– Sell
-11,199
Closed -$1.07M – 4414
2014
Q2 		$1.07M Sell
11,199
-27,634
-71% -$2.48M 0.14% 84
2014
Q1 		$3.53M Buy
38,833
+35,018
+918% +$3.4M 0.45% 42
2013
Q4 		$338K Buy
+3,815
New +$319K 0.06% 296

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

Tower Research Capital (TRC)'s BBH Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 260 shares — an estimated $43.1K sold.

Tower Research Capital (TRC) first reported a position in BBH in Q4 2013 and held it in 45 quarters. The position peaked at $4.84M in Q1 2015. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 260 VanEck Biotech ETF shares in Q4 2025, an estimated $43.1K.
  • Tower Research Capital (TRC) first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 45 quarters.
  • Tower Research Capital (TRC)'s VanEck Biotech ETF position peaked at $4.84M in Q1 2015.
  • 111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.